Substance use disorders (SUDs) have an enormous impact on public health. With classic
psychedelic-assisted therapies showing initial promise in treating multiple SUDs, it is …

Introduction Smoking-related diseases are major contributors to disability and shorter life
expectancy among opioid-dependent patients. Smoking prevalence is considerably higher …

Aims To study the impact of alcohol control policy measures (ie increases in taxation,
restrictions on availability, including minimum purchasing age regulations, legislation on …

This report presents the current status of alcohol consumption, alcohol-attributable harms
and the implementation of alcohol control policies in the WHO European Region, using …

Background The COVID-19 pandemic might impact substance use behaviours around the
globe. In this study, we investigate changes in alcohol and tobacco use in the second half of …

Because many forms of substance use are in the midst of ongoing, long-term period
fluctuations, traditional age–period cohort and other time–series models need to be …

Oxytocin is gaining traction in the treatment of various substance use disorders (SUD). We
performed a systematic review assessing the efficacy of oxytocin for treating different SUD …

Aims Children are an important group harmed by others' alcohol consumption. This study (1)
compared the risk of occurrence of child maltreatment among children exposed versus not …

Background Alcoholic cardiomyopathy (ACM) remains a significant public health issue with
a growing global burden. The burden of ACM in China and different regions remains poorly …

Background and aims One of the ways to address the treatment gap for substance use
disorders is to understand the barriers and facilitators to treatment. This study aimed to …